HLB

home

Author : adminDate : 2019-08-20 21:08

IR News Letter - Submit Final Abstract to ESMO / Neopharma / Patent. (08/20/2019)

IR News Letter - Pre-NDA Meeting (08/09/2019)

IR News Letter - Current Status of Clinical Trials and Indications for Rivoceranib (08/29/2019)